Cadrenal Therapeutics, Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-053074
- Form type
- 10-Q
- CIK
- 0001937993
- Primary document
- https://www.sec.gov/Archives/edgar/data/1937993/000121390026053074/ea0288837-10q_cadrenal.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Cadrenal Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.5M | - | - |
| Net Income | $-2.5M | - | - |
| Eps Basic | -1.04 | - | - |
| Eps Diluted | -1.04 | - | - |
| Cash And Equivalents | $2.3M | - | - |
| Total Assets | $2.9M | - | - |
| Total Liabilities | $1.1M | - | - |
| Shareholders Equity | $1.8M | - | - |
| Operating Cash Flow | $-3.0M | - | - |
| Capital Expenditures | $3,251 | - | - |